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Ischemic heart disease is one of the leading causes of death 
in the world. Although modern therapy of acute myocardial 
infarction (AMI) can reduce infarct size and result in an 
increased early survival rate, heart failure after AMI is still 
a major problem in survivors. Ventricular remodeling is 
critically important in heart failure after ischemia. It is 
characterized by changes in ventricular geometry and rigid-
ity, as well as phenotypic modifications and functional 
changes of cardiomyocytes [1]. Induction of pro-inflam- 
matory cytokines was proved to be associated with the onset 
and progression of ventricular remodeling [2]. While the 
heart is not a traditional cytokine-producing organ, cyto-
kines were found locally expressed within the myocardium 
after AMI in rats [3]. Pro-inflammatory cytokines could 
activate nuclear factor B (NF-B), a key transcriptional 
regulator of inflammation, which further induces cytokine 
production. This process forms an autocrine amplification 
loop. Modulation of the cytokines locally expressed in car-
diomyocytes per se represents a possible new target for in-
tervention in heart failure after AMI.  
Cytokines are produced soon after myocardial ischemic 
injury, tightly regulate apoptosis of cardiomyocytes, and 
trigger inflammatory responses. Generally, the main source 
of cytokines is immunocytes. Tumor necrosis factor- 
(TNF-), transforming growth factor- (TGF-) and mem-
bers of the interleukin (IL) family are secreted by cardio-
myocytes after AMI. Among these, TNF- is the most 
widely studied cytokine in cardiovascular disease. It is ini-
tially synthesized as a transmembrane protein (mTNF), after 
cleavage by TNF--converting enzyme, a free peptide 
(sTNF) is released into the extracellular space. Both forms 
have pleiotropic effects through binding to TNF- receptors 
(TNFRs). The TNF- level is elevated in patients with AMI, 
with the protein evenly distributed between cardiomyocytes 
and resident cardiac macrophages. This leads to defects in 
contractility, myocyte apoptosis, and inflammatory signal 
transduction, as well as extracellular matrix (ECM) synthe-
sis and cardiac regeneration at the chronic stage. We direct-
ly verified that TNF- could be secreted by hypoxic cardi-
omyocytes in vitro. Hypoxia induces stable expression and 
translocation of hypoxia inducible factor-1 (HIF-1), 
which binds to hypoxia response elements (HREs) in the 
TNF- gene (TNF) promoter, resulting in transcription of 
the gene. The predominant form of TNF- produced by 
hypoxic cardiomyocytes is mTNF, which was verified to be 
released via exosomes. Exosomes containing mTNF trans-
ferred it to the targeted cardiomyocytes, induced apoptosis, 
thus playing an autocrine role (Figure 1) [4]. TNFR1-  
containing exosome-like vesicles were also found in human 
plasma and modulated TNF-mediated inflammation [5]. 
TGF- was up-regulated in AMI animal models and pro-
gressive coronary artery occlusion. It critically regulates 
cytokine expression and fibrous tissue deposition, by medi-
ating myofibroblast differentiation and inducing ECM syn-
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Figure 1  Schematic diagram outlining the autocrine mechanism of tumor necrosis factor- (TNF-) produced by hypoxic cardiomyocytes. CBP/P300: 
CREB binding protein/EIA binding protein P300 coactivator; HIF: hypoxia inducible factor; HRE: hypoxia response element; MVB: multivesicular body; 
TNFR: tumor necrosis factor- receptor; Ub: ubiquitin. 
thesis. Among ILs, IL-1, IL-6, IL-10, and IL-33 were veri-
fied to be released by the myocardium after ischemic stress. 
IL-1 and IL-6 are pro-inflammatory cytokines, which ex-
hibit overlapping characteristics with TNF-. Both these 
pro-inflammatory cytokines are up-regulated in an AMI 
model and contribute to ventricular remodeling. IL-10 and 
IL-33 are potent anti-inflammatory cytokines, which inhibit 
macrophage infiltration and the production of pro-     
inflammatory cytokines, ultimately contributing to im-
proved ventricular function.  
The exact autocrine mechanism of cytokines in cardio-
myocytes involves stressors triggered by ischemia, activa-
tion of related signal transduction pathways, critical tran-
scription factors, and the secretory pathway. Ischemia and 
hypoxia are direct triggers for cytokine production in AMI. 
They can activate the neuro-endocrine-immune system, 
leading to renin-angiotensin-aldosterone system activation, 
an excited sympathetic nervous system, and inflammatory 
cytokine synthesis.  
Mitogen-activated protein kinase (MAPK) subfamilies 
constitute the common pathway after neuro-endocrine-  
immune system activation. Three major MAPK subfamilies 
found in the heart include extracellular signal-regulated 
kinases (ERKs), c-Jun N-terminal kinases (JNKs), and p38 
MAPKs. Activation of p38 MAPKs is sufficient to induce 
IL-1, IL-6, and TNF- expression in cardiomyocytes, and 
contributes to ventricular remodeling. JNK and ERK sig-
naling pathways are activated after ischemia; whether they 
can induce cytokine production, needs further investigation. 
The receptor activator of NF-B ligand (RANKL) signaling 
pathway is another important pathway that was found to be 
activated in ischemic heart tissue and specifically induce 
TNF-, IL-1, and IL-1 expression during myocardial 
remodeling [6].  
Transcriptional regulation occurs via specific interaction 
of nuclear transacting protein factors with corresponding 
cis-elements in the gene promoter. HIF-1 is the master fac-
tor and direct regulator of cellular adaption to hypoxic stress. 
It is a hetero-dimeric protein complex composed of HIF-1 
and HIF-1. HIF-1 is degraded through the VHL (von 
Vippel-Lindau)-dependent ubiquitin-proteasome pathway 
under normoxia. This pathway is blocked under hypoxia. 
Accumulated HIF-1 dimerizes with HIF-1, forming HIF, 
which induces transcription via interaction with HREs con-
taining a core 5′-CGTG-3′ motif in the regulatory regions of 
the target genes. In recent studies, HIF-1 was found to 
take part in cytokine transcriptional regulation. Both the 
IL1B and IL20 genes carry HREs in their promoter regions 
that were verified to be functional. In our study, HIF-1 
was activated and stably expressed in primary cultured car-
diomyocytes under hypoxia, bound the HRE between nu-
cleotides 1295 and 1292 in the 5′-flanking region of the 
TNF- promoter as the functional cis-acting element re-
quired for hypoxic activation, and eventually induced TNF 
gene transcription and protein biogenesis [4]. NF-B is an-
other transcription factor responsible for TNF- expression. 
It is comprised of two subunits and retained in the cyto-
plasm by interaction with the protein inhibitor of B (IB). 
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IB is phosphorylated after NF-B activation which leads 
to IB degradation and NF-B translocation. 
Cytokine secretion is a complex process that is highly 
regulated via different pathways. The majority of cytokines 
are processed and transported through the classical pathway. 
In this pathway, cytokines are synthesized in the endoplas-
mic reticulum (ER) and trafficked to the Golgi complex for 
further processing. In the trans-Golgi network, they are 
loaded into vesicles for constitutive delivery to the cell sur-
face or transit via recycling endosomes. In a non-classical 
secretory pathway, cytokines move directly from their point 
of synthesis in the cytoplasm to the external milieu. Differ-
ent mechanisms have been proposed regarding the passage 
through the plasma membrane, including the use of mem-
brane transporters, exosome release from multi-vesicular 
bodies, and micro-vesicle shedding from the plasma mem-
brane. The exact mechanism is often specific to a unique 
cytokine and cell type. TNF- secretion by macrophages 
occurs via the classical secretory pathway. Macrophages 
also secrete IL-6 and IL-10 by the classical pathway by re-
cycling endosomes [7]. Cytokines such as IL-1, lacking the 
N-terminal signal sequence required for ER entry, are syn-
thesized in the cytoplasm, and thereafter released from cells 
by non-classical pathways [8]. Our group [4] found that 
TNF- was released through exosomes from hypoxic car-
diomyocytes. Exosomes are nano-vesicles released from the 
cells via exocytosis; they have been shown to carry and 
transfer a wide range of cargos, including proteins, lipids, 
and nucleic acids, and mediate proximal as well as distal 
cell-to-cell signaling.  
During heart failure after AMI, ischemic stimulation ac-
tivates HIF-1 and the neuro-endocrine-immune system. 
Further activation of NF-B induces transcription of cyto- 
kines, which are trafficked to the targets cells through dif-
ferent pathways. Accumulating evidence has proved that 
cytokines are synthesized by ischemic cardiomyocytes, 
which provides a new insight into the inflammatory pro-
cesses involved in ventricular remodeling. Increase in pub-
lished studies on this topic makes exosomes (the newly re-
ported carriers in cytokine transfer) the possible and poten-
tial targets for immune modulation in future. 
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